[{"Assets_0_FY_USD":249777000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.575,"EarningsPerShareBasic_1_FY_USD":0.14,"EarningsPerShareBasic_4_FY_USD":0.51,"EarningsPerShareDiluted_1_FY_USD":0.13,"EarningsPerShareDiluted_4_FY_USD":0.51,"NetIncomeLoss_1_FY_USD":5726000.0,"NetIncomeLoss_4_FY_USD":21557000.0,"StockholdersEquity_0_FY_USD":169585000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":42571000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":42188000.0,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-K","period":"20170930","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20171129"}]